A small exploratory trial shows that treatment with testosterone gel was safe and well tolerated by men with relapsing remitting MS. Some improvement in cognitive performance and slowing of brain atrophy was seen, but there was no effect on gadolinium-enhancing lesions on MRI.
Medscape Medical News
Susan Jeffrey
More...